ADBE vs UNH: Which Is the Better Buy?

Side-by-side comparison of Adobe Inc. and UnitedHealth Group Incorporated β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-23.
Adobe Inc. Β· Technology
$238.25
+13.5% upside to fair value
Med Conviction Grade B High Quality
VS
UnitedHealth Group Incorporated Β· Healthcare
$375.21
+28.2% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
UNH has more upside to fair value (+28.2%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric ADBE UNH
Current Price $238.25 $375.21
Fair Value Estimate $270.38 $481.06
Upside to Fair Value +13.5% +28.2%
Market Cap $94.7B $340.7B
Forward P/E β€” β€”
EV / EBITDA 9.5x 15.0x
Price / Sales 3.6x 0.8x
Price / FCF 8.6x 14.4x
Revenue Growth YoY +12.9% +0.4%
Gross Margin 89.1% 22.5%
Operating Margin 35.7% 4.8%
Return on Equity 62.9% 14.6%
Dividend Yield 0% 2.41%
FCF Yield 11.63% 6.95%
Analyst Consensus Hold Strong Buy
Investment Thesis
ADBE β€” Adobe Inc.
Adobe is a global software provider organized into Digital Media, Digital Experience, and Publishing and Advertising, with Creative Cloud as its subscription flagship and Document Cloud as its cloud-native document platform. The business quality is high on fundamentals: TTM gross margin of 89.1%, TTM operating margin of 35.7%, TTM net margin of 28.0%, ROE of 62.9%, and free cash flow of $27.69 pe…
UNH β€” UnitedHealth Group Incorporated
UnitedHealth Group is the largest diversified healthcare enterprise in the United States, operating UnitedHealthcare insurance plans alongside Optum Health, Optum Insight, and Optum Rx, with 390,000 employees and a market capitalization of $340.74 billion. The business quality is high: a 14.6% return on equity, $26.07 in free cash flow per share, and a P/FCF of 14.39 demonstrate strong cash gener…
Accumulation Zones
Metric ADBE UNH
Zone Low $202.78 $360.80
Zone High $229.82 $408.90
In Buy Zone? No Yes
← ADBE Research    UNH Research β†’    All Research